1. Home
  2. SYBX vs GORV Comparison

SYBX vs GORV Comparison

Compare SYBX & GORV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • GORV
  • Stock Information
  • Founded
  • SYBX N/A
  • GORV 1976
  • Country
  • SYBX United States
  • GORV United States
  • Employees
  • SYBX N/A
  • GORV N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • GORV Retail-Auto Dealers and Gas Stations
  • Sector
  • SYBX Health Care
  • GORV Consumer Discretionary
  • Exchange
  • SYBX Nasdaq
  • GORV Nasdaq
  • Market Cap
  • SYBX 16.4M
  • GORV 15.5M
  • IPO Year
  • SYBX N/A
  • GORV 2015
  • Fundamental
  • Price
  • SYBX $1.46
  • GORV $3.58
  • Analyst Decision
  • SYBX
  • GORV Hold
  • Analyst Count
  • SYBX 0
  • GORV 2
  • Target Price
  • SYBX N/A
  • GORV $60.00
  • AVG Volume (30 Days)
  • SYBX 53.6K
  • GORV 24.6K
  • Earning Date
  • SYBX 08-07-2025
  • GORV 08-14-2025
  • Dividend Yield
  • SYBX N/A
  • GORV N/A
  • EPS Growth
  • SYBX N/A
  • GORV N/A
  • EPS
  • SYBX N/A
  • GORV N/A
  • Revenue
  • SYBX N/A
  • GORV $662,952,000.00
  • Revenue This Year
  • SYBX N/A
  • GORV $15.65
  • Revenue Next Year
  • SYBX N/A
  • GORV $20.54
  • P/E Ratio
  • SYBX N/A
  • GORV N/A
  • Revenue Growth
  • SYBX N/A
  • GORV N/A
  • 52 Week Low
  • SYBX $0.90
  • GORV $3.46
  • 52 Week High
  • SYBX $1.96
  • GORV $60.59
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 52.54
  • GORV 29.01
  • Support Level
  • SYBX $1.33
  • GORV $3.53
  • Resistance Level
  • SYBX $1.67
  • GORV $3.78
  • Average True Range (ATR)
  • SYBX 0.12
  • GORV 0.45
  • MACD
  • SYBX -0.01
  • GORV -0.01
  • Stochastic Oscillator
  • SYBX 38.24
  • GORV 5.73

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About GORV Lazydays Holdings Inc.

Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.

Share on Social Networks: